Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
 | ALVOTECH | 5 | - | +1,82 % | |
 | FESTI | 1 | 4 | - | |
| AMAROQ | - | 5 | +1,87 % | ||
| HEIMAR | - | 3 | - | |
| JBT MAREL | - | 2 | 0,00 % | ||
| ARION BANK | - | 1 | +0,87 % | ||
| EIMSKIP | - | 1 | - | |
| ICELANDAIR GROUP HF | - | - | - | |
| HAGAR | - | - | - | |
| SKAGI | - | - | - |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Festi hf.: Major shareholder announcement from Lífeyrissjóður verzlunarmanna | 3 | GlobeNewswire (USA) | ||
| Do | Alvotech - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| Do | Alvotech, Advanz Pharma secure European approval for Gobivaz, Simponi biosimilar | 3 | Seeking Alpha | ||
| Do | European Commission approves Alvotech's biosimilar golimumab | 7 | Investing.com | ||
| Do | Alvotech and Advanz Pharma Receive Marketing Approval Across the European Economic Area for Gobivaz, a First-in-Market Biosimilar to Simponi (golimumab) | 3 | GlobeNewswire (USA) | ||
| Do | Alvotech S.A.: Alvotech and Advanz Pharma Receive Marketing Approval Across the European Economic Area for Gobivaz, a First-in-Market Biosimilar to Simponi (golimumab) | 759 | GlobeNewswire (Europe) | Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma Holdco Limited ("Advanz Pharma"), a... ► Artikel lesen | |
| Mi | Amaroq Ltd: Amaroq extends debt financing with Landsbankinn | 2 | Stockwatch | ||
| Mi | Amaroq improves terms of its debt financing package | 4 | Alliance News | ||
| Mi | Amaroq secures improved debt financing terms with Landsbankinn | 4 | Sharecast | ||
| Mi | Amaroq Ltd.: Improved debt financing agreement | 100 | GlobeNewswire (Europe) | Reykjavík, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Amaroq Ltd.("Amaroq" or the "Company") Improved debt financing agreement TORONTO, ONTARIO - 19 November 2025 - Amaroq Ltd. (AIM, TSX-V, NASDAQ Iceland:... ► Artikel lesen | |
| Di | Oculis Holding AG: Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities | 3 | GlobeNewswire (USA) | ||
| Di | Íslandsbanki hf.: Moody's Ratings affirms Íslandsbanki's A3 long-term issuer ratings with a stable outlook | 59 | GlobeNewswire (Europe) | Moody's Ratings (Moody's) has today affirmed Íslandsbanki's A3 long-term foreign and local currency issuer ratings, the A2 long-term and P-1 short-term foreign and local currency deposit ratings, and... ► Artikel lesen | |
| Mo | Eimskipafelag Islands hf.: Transaction in relation to a share buy-back program | 2 | GlobeNewswire (USA) | ||
| 14.11. | AMAROQ LTD. reports Q3 results | 2 | Seeking Alpha | ||
| 14.11. | Amaroq reports higher revenue, progress at Nalunaq | 4 | Sharecast | ||
| 14.11. | Amaroq reports narrowed loss amid developer to producer transition | 4 | Alliance News | ||
| 14.11. | Amaroq Minerals steigert Goldproduktion und stärkt strategischen Fokus auf Grönland | 4 | Investing.com Deutsch | ||
| 14.11. | Amaroq Minerals Q3 2025 slides: Gold production ramps up amid strategic Greenland focus | 2 | Investing.com | ||
| 14.11. | Earnings Call Transkript: Amaroq Minerals zeigt in Q3 2025 operative Fortschritte | 3 | Investing.com Deutsch | ||
| 14.11. | Amaroq Ltd.: Q3 2025 Financial Results | 290 | GlobeNewswire (Europe) | Reykjavík, Nov. 14, 2025 (GLOBE NEWSWIRE) -- ("Amaroq" or the "Company") Q3 2025 Financial Results Growing revenues and restart of operations TORONTO, ONTARIO - 14 November 2025 - Amaroq Ltd. (AIM... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .